Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 6,365 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0203 | 2.86% | 0.73 | 08:13:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7097 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 15 | 6,365 | - | 0.53 - 1.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:13:29 | 3 | $ 0.7451 | USD |
Vaxart Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 123.44M | 173.86M | - | 7.38M | -82.47M | -0.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.86 | 0.8997 | 0.7001 | 0.7555969 | 1,353,578 | -0.13 | -15.12% |
| 1 Month | 1.33 | 1.41 | 0.7001 | 1.02 | 1,702,992 | -0.60 | -45.11% |
| 3 Months | 1.21 | 1.54 | 0.7001 | 1.16 | 1,741,609 | -0.48 | -39.67% |
| 6 Months | 0.649 | 1.54 | 0.53 | 0.9877334 | 1,500,137 | 0.081 | 12.48% |
| 1 Year | 0.7232 | 1.59 | 0.53 | 0.9524611 | 1,550,498 | 0.0068 | 0.94% |
| 3 Years | 5.68 | 11.108 | 0.53 | 5.76 | 4,005,726 | -4.95 | -87.15% |
| 5 Years | 0.781 | 24.90 | 0.2543 | 6.72 | 6,437,187 | -0.051 | -6.53% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
